← Open Payments lookup

MATTHEW SCHULTZ: Open Payments

NPI 1043804966 · HUNTINGDON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$528 in 25 payments from 10 companies in 2025. Trend: 2023 $302 · 2024 $676 · 2025 $528

Food & beverage: $451Education: $77
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.4$105
Janssen Biotech, Inc.1$77
Aimmune Therapeutics, Inc.4$71
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$62
Phathom Pharmaceuticals, Inc.3$44
Ardelyx, Inc.2$38
Ipsen Biopharmaceuticals, Inc2$37
PFIZER INC.2$32
ABBVIE INC.2$31
Lilly USA, LLC2$30

Products named: ENTYVIO, TREMFYA, XIFAXAN, ZENPEP, VOQUEZNA, IBSRELA, IQIRVO, VELSIPITY.

Industry payments across PA — which companies pay providers there.